The Oncosearch | Oncotarget

Decreased expression of the translation factor eIF3e induces senescence in breast cancer cells via suppression of PARP1 and activation of mTORC1 Research Paper

Christelle Morris, Sébastien Durand, Pierre Jalinot

Published Mar 13, 2021 · Vol. 12, No. 7 · pp. 649-664

Keywords: breast cancer, senescence-associated secretory phenotype, eIF3, PARP1, mTORC1

Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine Research Paper

Balraj Singh, Vanessa N. Sarli, Anthony Lucci

Published Mar 12, 2021 · Vol. 12, No. 7 · pp. 626-637

Keywords: resistant TNBC, minimal residual disease, intratumor heterogeneity, breast cancer relapse, metastasis prevention

Up to your NEK2 in CIN Editorial

Darcie D. Seachrist, Lindsey J. Anstine, Ruth A. Keri

Published Mar 6, 2021 · Vol. 12, No. 8 · pp. 723-725

Keywords: LIN9, NEK2, chromosomal instability, taxane resistance, breast cancer

Up to your NEK2 in CIN Editorial

Darcie D. Seachrist, Lindsey J. Anstine, Ruth A. Keri

Published Mar 6, 2021

Keywords: LIN9, NEK2, chromosomal instability, taxane resistance, breast cancer

Up to your NEK2 in CIN Editorial

Darcie D. Seachrist, Lindsey J. Anstine, Ruth A. Keri

Published Mar 6, 2021

Keywords: LIN9, NEK2, chromosomal instability, taxane resistance, breast cancer

Raman spectroscopy determination of the mineral characteristics of microcalcifications in breast cancer: a way towards an improved screening approach Editorial

Fabio Corsi, Carlo Morasso

Published Mar 4, 2021 · Vol. 12, No. 10 · pp. 950-951

Keywords: Raman spectroscopy, microcalcifications, breast cancer

Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients Research Paper

Duna H. Barakeh, Rasha Aljelaify, Yara Bashawri, Amal Almutairi, Fatimah Alqubaishi, Mohammed Alnamnakani, Latifa Almubarak, Abdulrahman Al Naeem, Fatema Almushawah, May Alrashed, Malak Abedalthagafi

Published Feb 27, 2021 · Vol. 12, No. 7 · pp. 686-697

Keywords: breast cancer, PIK3CA, BCa, Saudi Arabia, BRCA

Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases? Editorial

Ilana Schlam, Sara M. Tolaney

Published Feb 19, 2021 · Vol. 12, No. 9 · pp. 873-875

Keywords: breast cancer, brain metastasis, leptomeningeal disease, CDK 4/6 inhibitors

Innovating and expanding weight loss strategies for breast cancer survivors Editorial

Jennifer Y. Sheng, Vered Stearns

Published Feb 9, 2021 · Vol. 12, No. 6 · pp. 521-524

Keywords: breast cancer, obesity, lifestyle interventions

The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy Research Paper

H.M.C. Shantha Kumara, Elie Sutton, Otavia L. Caballero, Tao Su, Xiaohong Yan, Aqeel Ahmed, Sonali A.C. Herath, Vesna Cekic, Linda Njoh, Daniel D. Kirchoff, Richard L. Whelan

Published Feb 9, 2021 · Vol. 12, No. 5 · pp. 412-421

Keywords: cancer testis antigens, colorectal cancer, CABYR a/b, c

Quantitative proteome profiling stratifies fibroepithelial lesions of the breast Research Paper

Aviral Kumar, David S. Nayakanti, Kiran K. Mangalaparthi, Veena Gopinath, Nandyala Venkat Narsimha Reddy, Krishna Govindan, Geeta Voolapalli, Prashant Kumar, Lekha Dinesh Kumar

Published Feb 3, 2021 · Vol. 12, No. 5 · pp. 507-518

Keywords: breast tumors, fibroepithelial lesions, phyllodes, iTRAQ, quantitative proteomics

Correction: Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers Correction

Ye Zhang, Xiujuan Qu, Yuee Teng, Zhi Li, Ling Xu, Jing Liu, Yanju Ma, Yibo Fan, Ce Li, Shizhou Liu, Zhenning Wang, Xuejun Hu, Jingdong Zhang, Yunpeng Liu

Published Jan 30, 2021 · Vol. 12, No. 16 · pp. 1634-1637

Tumor mutational burden as a predictor of immunotherapy response in breast cancer Research Perspective

Tess A. O’Meara, Sara M. Tolaney

Published Jan 23, 2021 · Vol. 12, No. 5 · pp. 394-400

Keywords: breast cancer, immunotherapy, tumor mutational burden

Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma Research Paper

Rolando Pérez-Lorenzo, Stephanie O. Erjavec, Angela M. Christiano, Raphael Clynes

Published Jan 6, 2021 · Vol. 12, No. 2 · pp. 66-80

Keywords: anti-tumor antibodies, targeted therapy, immunotherapy, combination therapies, melanoma

A priori prediction of response in multicentre locally advanced breast cancer (LABC) patients using quantitative ultrasound and derivative texture methods Research Paper

Laurentius O. Osapoetra, Lakshmanan Sannachi, Karina Quiaoit, Archya Dasgupta, Daniel DiCenzo, Kashuf Fatima, Frances Wright, Robert Dinniwell, Maureen Trudeau, Sonal Gandhi, William Tran, Michael C. Kolios, Wei Yang, Gregory J. Czarnota

Published Jan 6, 2021 · Vol. 12, No. 2 · pp. 81-94

Keywords: radiomics, breast cancer, texture-derivate, quantitative ultrasound, neoadjuvant chemotherapy

Clinical application of liquid biopsies to detect somatic BRCA1/2 mutations and guide potential therapeutic intervention for patients with metastatic breast cancer Research Perspective

Neelima Vidula, Leif W. Ellisen, Aditya Bardia

Published Dec 28, 2020 · Vol. 12, No. 2 · pp. 63-65

Keywords: cell-free DNA, BRCA1/2, PARP inhibitor, metastatic breast cancer, plasma based genotyping

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors Editorial

Erika J. Crosby, H. Kim Lyerly, Zachary C. Hartman

Published Dec 26, 2020 · Vol. 12, No. 1 · pp. 1-3

Keywords: breast cancer, tumor immunology animal models, T cell exhaustion, immune responses to cancer, tumor antigens/neoantigens

Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study Research Paper

Kazuhiro Kitajima, Yasuo Miyoshi, Tetsuro Sekine, Hiroyuki Takei, Kimiteru Ito, Akihiko Suto, Hayato Kaida, Kazunari Ishii, Hiromitsu Daisaki, Koichiro Yamakado

Published Dec 16, 2020 · Vol. 12, No. 2 · pp. 95-105

Keywords: breast cancer, survival, fluorodeoxyglucose (FDG), positron emission tomography-computed tomography (PET-CT), harmonization

Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation Case Report

Karam Khaddour, Joshua Dowling, Jiayi Huang, Martha Council, David Chen, Lynn Cornelius, Tanner Johanns, Sonika Dahiya, George Ansstas

Published Dec 13, 2020 · Vol. 11, No. 52 · pp. 4836-4844

Keywords: metastatic melanoma, immune checkpoint inhibitor, temozolomide, acquired resistance, beta-2 microglobulin

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer Research Paper

Michael Rees, Chris Smith, Peter Barrett-Lee, Steve Hiscox

Published Dec 11, 2020 · Vol. 11, No. 51 · pp. 4722-4734

Keywords: breast cancer, PELP-1, ER+, invasion

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Decreased expression of the translation factor eIF3e induces senescence in breast cancer cells via suppression of PARP1 and activation of mTORC1 Research Paper

Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine Research Paper

Up to your NEK2 in CIN Editorial

Up to your NEK2 in CIN Editorial

Up to your NEK2 in CIN Editorial

Raman spectroscopy determination of the mineral characteristics of microcalcifications in breast cancer: a way towards an improved screening approach Editorial

Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients Research Paper

Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases? Editorial

Innovating and expanding weight loss strategies for breast cancer survivors Editorial

The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy Research Paper

Quantitative proteome profiling stratifies fibroepithelial lesions of the breast Research Paper

Correction: Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers Correction

Tumor mutational burden as a predictor of immunotherapy response in breast cancer Research Perspective

Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma Research Paper

A priori prediction of response in multicentre locally advanced breast cancer (LABC) patients using quantitative ultrasound and derivative texture methods Research Paper

Clinical application of liquid biopsies to detect somatic BRCA1/2 mutations and guide potential therapeutic intervention for patients with metastatic breast cancer Research Perspective

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors Editorial

Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study Research Paper

Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation Case Report

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Decreased expression of the translation factor eIF3e induces senescence in breast cancer cells via suppression of PARP1 and activation of mTORC1 Research Paper

Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine Research Paper

Up to your NEK2 in CIN Editorial

Up to your NEK2 in CIN Editorial

Up to your NEK2 in CIN Editorial

Raman spectroscopy determination of the mineral characteristics of microcalcifications in breast cancer: a way towards an improved screening approach Editorial

Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients Research Paper

Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases? Editorial

Innovating and expanding weight loss strategies for breast cancer survivors Editorial

The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy Research Paper

Quantitative proteome profiling stratifies fibroepithelial lesions of the breast Research Paper

Correction: Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers Correction

Tumor mutational burden as a predictor of immunotherapy response in breast cancer Research Perspective

Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma Research Paper

A priori prediction of response in multicentre locally advanced breast cancer (LABC) patients using quantitative ultrasound and derivative texture methods Research Paper

Clinical application of liquid biopsies to detect somatic BRCA1/2 mutations and guide potential therapeutic intervention for patients with metastatic breast cancer Research Perspective

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors Editorial

Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study Research Paper

Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation Case Report

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer Research Paper